First, I think it's time to get out of the super large cap biotechs. AMGN has been leading to the upside along with names like GILD. However, if you look at the IBB/SPY ratio, we have clean sells and names like AMGN were actually weak in a 5%+ market... That is a big signal to me.

With real yields starting to back off a bit, there could be a strong move in gold miners on a sustained timeframe. Check out this GDX/SPY ratio chart.

Barrick (GOLD) has a really nice risk reward against the recent low.

TSLA still has an active TD 13 Combo

Semi-conductors relative to the S&P have a weekly 13 buy

Little bit of a tight risk-reward short setup on DKS against the recent range highs.

GOSS came up on my screener, but this is a very high volatility biotech. Do your own due diligence on this one.

Keep an eye out for a little squeeze in natural gas, still.

Seeing a really nice squeeze setup on Block (FKA Square). This is @jack's payment/crypto play.

Keep an eye on IPO relative strength coming back. The weekly ratio against the S&P is in a hotzone of DeMARK risk levels.